Diabetes
From the Journals
Tirzepatide questions persist despite serial phase 3 success in type 2 diabetes
Primary results from the SURPASS-3 trial add to accumulating safety and efficacy evidence for the new “twincretin” tirzepatide, but questions...
Latest News
Ultraprocessed foods comprise most of the calories for youths
Disparities by race and ethnicity showed even higher consumption of ultraprocessed foods over past 20 years by Black and Hispanic youth.
Latest News
Task force affirms routine gestational diabetes testing
USPSTF recommendation includes asymptomatic women with no previous diabetes diagnosis at 24 weeks’ gestation or later.
From the Journals
Tackle obesity to drop risk for secondary cardiac event
‘It seems that obesity is not considered by physicians as a serious medical problem, which requires attention’ to lower risk for a secondary...
From the Journals
Plant-based lignan intake linked to lower CHD risk
Long-term consumption of lignans, polyphenols produced by plants, was associated with a reduced risk of coronary heart disease in this prospective...
From the Journals
Half abandon metformin within a year of diabetes diagnosis
Multiple factors are blamed for the drop-off, while improved communication, follow-up, and medication adjustment are advised as remedies.
News
FDA clears app for FreeStyle Libre 2 glucose monitor
System includes optional alarms; app allows for remote monitoring.
From the Journals
Certain gut bacteria tied to lower risk of diabetes
Greater gut microbial diversity and abundance of 12 types of butyrate-producing bacteria may hinder the development of type 2 diabetes, a...
Feature
Diabetes drug’s new weight-loss indication fuels cost-benefit debate
Health plans’ coverage of semaglutide, branded as Wegovy – which has a $1,300-a-month price tag – is not a sure thing.
From the Journals
‘Shocking’ early complications from teen-onset type 2 diabetes
Almost two-thirds of study participants had at least one diabetes complication in young adulthood, around 15 years after diagnosis. A handful died...
Conference Coverage
ESC heart failure guideline to integrate bounty of new meds
It has a simple answer to a seemingly complex issue: how to merge the newly approved with mainstay drug therapies. And it conditionally okays meds...